vascularpharma.com

Vascular Pharmaceuticals - Home

30% of the 382m diabetics globally. Now enrolling Phase 2 clinical trial. Our novel scientific approach. Slows the progression of diabetic. A long-term, committed. Partnership speaks to the. Value of our work. Vascular Pharmaceuticals is addressing the complications of diabetes. Vascular Pharmaceuticals is pioneering a new approach to treat one of the most common complications of diabetes, diabetic nephropathy. Is in Phase 2 clinical trials. News, Events and Publications.

http://www.vascularpharma.com/

OVERVIEW OF vascularpharma.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

14

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR VASCULARPHARMA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.4 out of 5 with 7 reviews

5 star

0

4 star

3

3 star

4

2 star

0

1 star

0

Hey there! Start your review of vascularpharma.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.7 seconds

CONTACTS AT VASCULARPHARMA.COM

Vascular Pharmaceuticals

Stacy Hammond

116 Ma●●●●●● Drive

Chap●●●●Hill , North Carolina, 27599

United States

1.91●●●●7933

st●●●●●●●●●●●●@vascularpharma.com

View this contact

HJB Design Services

Hal Bredbenner

8513 S●●●●●●ar Dr.

Ra●●gh , North Carolina, 27606

United States

1.91●●●●7295

ha●@hjbnet.com

View this contact

HJB Design Services

Hal Bredbenner

8513 S●●●●●●ar Dr.

Ra●●gh , North Carolina, 27606

United States

1.91●●●●7295

ha●@hjbnet.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2009 November 12
UPDATED: 2013 November 20
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

14

YEARS
5

MONTHS
25

DAYS

NAME SERVERS

1: ns03.domaincontrol.com
2: ns04.domaincontrol.com

REGISTRAR

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

PAGES IN
THIS WEBSITE

14

SSL

EXTERNAL LINKS

6

SITE IP

192.186.201.73

LOAD TIME

0.719 sec

SCORE

6.2

PAGE TITLE

Vascular Pharmaceuticals - Home | vascularpharma.com Reviews

<META> DESCRIPTION

30% of the 382m diabetics globally. Now enrolling Phase 2 clinical trial. Our novel scientific approach. Slows the progression of diabetic. A long-term, committed. Partnership speaks to the. Value of our work. Vascular Pharmaceuticals is addressing the complications of diabetes. Vascular Pharmaceuticals is pioneering a new approach to treat one of the most common complications of diabetes, diabetic nephropathy. Is in Phase 2 clinical trials. News, Events and Publications.

<META> KEYWORDS

1 science

2 clinical trials

3 diabetic nephropathy

4 news/publications

5 will develop nephropathy

6 kidney disease

7 review the science

8 information for patients

9 management

10 board of directors

CONTENT

Page content here

KEYWORDS ON PAGE

science,clinical trials,diabetic nephropathy,news/publications,will develop nephropathy,kidney disease,review the science,information for patients,management,board of directors,investors and partners,clinical sites,patients,press releases,publications

SERVER

Apache/2.4.12

POWERED BY

PHP/5.4.43

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Vascular Pharmaceuticals - Home | vascularpharma.com Reviews

https://vascularpharma.com

30% of the 382m diabetics globally. Now enrolling Phase 2 clinical trial. Our novel scientific approach. Slows the progression of diabetic. A long-term, committed. Partnership speaks to the. Value of our work. Vascular Pharmaceuticals is addressing the complications of diabetes. Vascular Pharmaceuticals is pioneering a new approach to treat one of the most common complications of diabetes, diabetic nephropathy. Is in Phase 2 clinical trials. News, Events and Publications.

INTERNAL PAGES

vascularpharma.com

1

Vascular Pharmaceuticals - Board of Directors

http://www.vascularpharma.com/company/board-of-directors

David Clemmons, M.D., Co-Founder, Chief Scientific Officer, VPI. Elizabeth Stoner, M.D., Chief Development Officer, VPI and Managing Director, MPM Ventures. Richard Kent, M.D., Venture Partner at Intersouth Partners. Marian Nakada, Ph.D., Vice President, Venture Investments, Johnson and Johnson Development Corporation, Board Observer. Richard J. Shea, Chief Executive Officer, VPI. Beni Rovinski, Ph.D., Managing Director, Lumira Capital. Vascular Pharmaceuticals Completes $9 Million Expansion.

2

Vascular Pharmaceuticals - resources and support for individuals with diabetic nephropathy

http://www.vascularpharma.com/clinical-trials/patients

Additional information, resources and support for individuals living with diabetic nephropathy is available through the following advocacy and professional organizations:. American Society for Nephrology. For more information about participating in a clinical trial, contact . Vascular Pharmaceuticals Completes $9 Million Expansion.

3

Vascular Pharmaceuticals - Team has broad expertise with focus in diabetic nephropathy

http://www.vascularpharma.com/company/management-team

The Vascular Pharmaceuticals management team brings deep operational, drug development and clinical expertise, with a particular focus in diabetic nephropathy. Our leaders promote strong collaboration and a patient-focused purpose throughout the organization. Richard J. Shea, MBA, Chief Executive Officer. David Clemmons, M.D., Co-Founder, Chief Scientific Officer. Laura Maile, Ph.D., Co-Founder, Director, Research and Development. Elizabeth Stoner, M.D., Chief Development Officer.

4

Vascular Pharmaceuticals - Press releases for Vascular Pharmaceuticals

http://www.vascularpharma.com/news-publications/vascular-pharmaceuticals-completes-16-million-equity-financing

Vascular Pharmaceuticals, Inc. Completes $16 Million Equity Financing, Signs Agreement with Janssen Biotech, Inc. CHAPEL HILL, NC, September 12, 2012,. Vascular Pharmaceuticals, Inc. (Vascular Pharma), a drug discovery company developing an innovative product to treat patients with complications arising from diabetes, announced today that it has successfully completed a $16 million Series A equity financing. Diabetic nephropathy is the leading cause of chronic kidney disease in the United States, with al...

5

Vascular Pharmaceuticals - Phase 2 clinical trial enrolling at 20+ sites in U.S.

http://www.vascularpharma.com/clinical-trials/clinical-sites

Vascular Pharmaceuticals Completes $9 Million Expansion.

UPGRADE TO PREMIUM TO VIEW 9 MORE

TOTAL PAGES IN THIS WEBSITE

14

LINKS TO THIS WEBSITE

lumiracapital.com

current | Lumira Capital

https://www.lumiracapital.com/portfolio/current

Skip to main content. Peter van der Velden MBA. Daniel Hetu MD, MBA. Richard Glickman L.L.D.(Hon). Dahlia Abbott Accounting / Office Manager. Maurice R. Ferré, MD Former President and Chief Executive Officer, MAKO Surgical Corp. Dr Theodore Witek Senior Vice President, Corporate Partnerships, Clinical and Medical Affairs at Theravance, Inc. Thomas Wellner Former President and CEO, CML HealthCare Inc. and co-CEO, LifeLabs. Ron Dunn Vice-President of MIS Canada for Mckesson Canada Corporation. The collabor...

lumiracapital.com

exits | Lumira Capital

https://www.lumiracapital.com/portfolio/exits

Skip to main content. Peter van der Velden MBA. Daniel Hetu MD, MBA. Richard Glickman L.L.D.(Hon). Dahlia Abbott Accounting / Office Manager. Maurice R. Ferré, MD Former President and Chief Executive Officer, MAKO Surgical Corp. Dr Theodore Witek Senior Vice President, Corporate Partnerships, Clinical and Medical Affairs at Theravance, Inc. Thomas Wellner Former President and CEO, CML HealthCare Inc. and co-CEO, LifeLabs. Ron Dunn Vice-President of MIS Canada for Mckesson Canada Corporation. Creating wea...

lumiracapital.com

Beni Rovinski PhD Managing Director | Lumira Capital

https://www.lumiracapital.com/investment-team/beni-rovinski

Skip to main content. Peter van der Velden MBA. Daniel Hetu MD, MBA. Richard Glickman L.L.D.(Hon). Dahlia Abbott Accounting / Office Manager. Maurice R. Ferré, MD Former President and Chief Executive Officer, MAKO Surgical Corp. Dr Theodore Witek Senior Vice President, Corporate Partnerships, Clinical and Medical Affairs at Theravance, Inc. Thomas Wellner Former President and CEO, CML HealthCare Inc. and co-CEO, LifeLabs. Ron Dunn Vice-President of MIS Canada for Mckesson Canada Corporation. Dr Theodore ...

blogs.esouthernoregon.com

Spiritual Perspectives on Health: A Mail Tribune Community Blog | From the Southern Oregon Media Group.

http://blogs.esouthernoregon.com/health-spiritual-perspectives

Spiritual Perspectives on Health: A Mail Tribune Community Blog. Divine Equity Key to Resolving the Housing Crisis. July 29, 2016. While today’s world class urban planners are aware of the bittersweet cost of growth, at least one, Don Masterson. Strips away infrastructure and politics and defines a truly healthy city as one that works for all its citizens and is ultimately about equity. The beauty of divine equity is that the human being is not asked to conform to an average standard and then rewarded wi...

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL LINKS TO THIS WEBSITE

6

OTHER SITES

vascularpedia.com

vascularpedia.com - This domain may be for sale!

Find the best information and most relevant links on all topics related to vascularpedia.com. This domain may be for sale!

vascularperiferico.com

Vascular Periferico Costa Rica | Dr Marcial Fallas Camacho

Dr Marcial Fallas Camacho. Cirujano Vascular Periférico. Las várices son dilataciones de las venas que se producen ante un mal funcionamiento de estas. Estos vasos son parte del sistema circulatorio que comprende una bomba que es el corazón, un sistema de distribución que son las arterias y uno de recolección que son las venas. Dentro de los factores no modificables tenemos, el género femenino, además la herencia y la edad. Existen varios tipos de dilataciones venosas:. Que son las que tienen un tamaño m...

vascularperspectives.com

Vascular Perspectives - Partners in interventional innovation

Raquo; Book a lab session. Join our mailing list. 35 atm balloon designed. To dilate stents and. For both workhorse and. OPN NC High Pressure. NIC Nano 0.85. BEO 15 NC OTW. Nic Nano .85mm. Nic Nano .85mm OTW. ASAHi Peripheral Guide Wires. Vascular Perspectives Ltd,. M22 4DB, UK. Tel: 44 (0) 161 491 0585. Fax: 44 (0) 161 282 6540.

vascularperth.com.au

Mr Gregory (Chui) Then. Vascular and Endovascular Surgeon. Email: info@murdochvascular.com.au. For Appointments and Enquiries. Tel: 61 (8) 9310 2377 (Mon - Fri). Fax: 61 (8) 9310 2322. Suite 27, Level 1, 3 Barry Marshall Parade, SJOG Wexford Medical Centre, Murdoch. CVS Suite , 40 Davenport Street, Karrinyup. CVS Suite 3 (South Consulting Rooms), 110 Lakes Road, Peel Health Campus, Mandurah. Suite 11, Level 1, Ellesmere Rd, SJOG Medical Centre, Mount Lawley. St John of God Hospital, Murdoch WA.

vascularpeset.com

vascularpeset | Servicio de Angiología, Cirugía Vascular y Endovascular del Hospital Dr. Peset - Inicio

Te damos la bienvenida a una nueva etapa de nuestro sitio web, en el que puedes encontrar información sobre nuestro Servicio, sobre nuestras actividades, sobre las enfermedades que tratamos y muchas otras cosas. Deseamos, tanto si eres paciente como si eres profesional, disfrutes y nos ayudes a mejorar este sitio web. Un saludo, Eduardo Ortiz Monzón. Realidad aumentada en el 59 Congreso de la SEACV. 59 Congreso Nacional de la Sociedad Española de Angiología y Cirugía Vascular.

vascularpharma.com

Vascular Pharmaceuticals - Home

30% of the 382m diabetics globally. Now enrolling Phase 2 clinical trial. Our novel scientific approach. Slows the progression of diabetic. A long-term, committed. Partnership speaks to the. Value of our work. Vascular Pharmaceuticals is addressing the complications of diabetes. Vascular Pharmaceuticals is pioneering a new approach to treat one of the most common complications of diabetes, diabetic nephropathy. Is in Phase 2 clinical trials. News, Events and Publications.

vascularphysicians.com

Minnesota Vascular Surgery Center

Breast Center of Maple Grove. To schedule a dialysis access consultation. 600 County Road D West, Suite 2. New Brighton, MN 55112. 2015 Minneapolis Radiology Associates, LLC. Privacy.

vascularplant.com

VascularPlant.com

VascularPlant.com is For Sale for $699.30!

vascularplant.museums.ualberta.ca

Vascular Plant Herbarium > Home

University of Alberta Vascular Plant Herbarium (ALTA) - University of Alberta Museums. University of Alberta Museums. The Vascular Plant Herbarium is part of the University of Alberta Museums, a network of 35 interdisciplinary museums and collections across campus, ranging from art to zoology. Totaling more than 17 million objects, the collections are used on a daily basis to fuel discovery and advance knowledge through teaching, research, and community outreach. View Details ».

vascularplants.com

vascularplus.com

www.vascularplus.com

Al mejor precio, crear tu web. De calidad. Además, servidor cloud.